Open an account

Buda Juice

BUDA · NYSE American

$7.35+$0.00 (+0.00%)TodayMarket closed ·
Prev close $7.35

About BUDA

Buda Juice, Inc. engages in the provision of fruit and vegetable beverages. The company is headquartered in Dallas, Texas. The company went IPO on 2026-01-08. The firm offers an end-to-end cold chain platform that always delivers cold, freshly crafted juice, lemonades and wellness shots to grocery retailers in Texas. Its product portfolio consists of fresh citrus juice, a fresh citrus-based line of lemonades and wellness shot offerings across multiple brand lines and retail customers, all produced using its cold chain process. Its products include Buda Juice (Organic), Buda Fresh - Value-Forward Offering (Non-Organic), and Private Label Products (Non-organic and Organic). Buda Fresh includes Fresh 12 oz Lime Juice, 16 oz and 128 oz Lemon Juice, Fresh Orange and Grapefruit Juice (16 oz, 32 oz and 52 oz), and Fresh Citrus-based Lemonades and Limeades (16 oz and 52 oz). Private Label Products include Fresh Citrus Line (52 oz) and Fresh Citrus-based Lemonades and Limeades (52 oz).

Employees
0
Headquarters
Dallas, Texas
Listed
Jan 8, 2026
Sector
Consumer Staples
Industry
Food Products
Website
budajuice.com

BUDA key statistics

Market cap
92.36M
Price-earnings ratio
0.00
Dividend yield
3.19%
Average volume
4.67K
Volume
4.81K
Open price
$7.22
High today
$7.45
Low today
$7.20
52 Week high
$12.00
52 Week low
$6.25

Buda Juice (BUDA) at a glance

As of Oct 20, 2026, Buda Juice (BUDA) shares are priced at $7.35, giving the company a market cap of 92.36M, a price-to-earnings ratio of 0.00 and a dividend yield of 3.19%.

Today the stock has traded between $7.20 and $7.45. The current price is 2.1% above the day's low and 1.3% below its high.

Volume so far is 4.81K shares, in line with the average of 4.67K shares a day.

Over the past year Buda Juice has ranged from $6.25 to $12.00, and now sits 19% of the way up that range.

Buda Juice met or beat analyst EPS estimates in 1 of the last 2 quarters. In Q2 FY26 it reported $0.04 per share against an estimate of $0.051.

The average analyst price target is $13.26, 80.4% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 2 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 4 analystsAvg $13.26
Low
$12.12
Now
$7.35
High
$14.70

BUDA earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 1 of the last 2 quarters, by 63.4% on average.

  1. Q1 FY26: reported $0.05 per share against an estimate of $0.0306
  2. Q2 FY26: reported $0.04 per share against an estimate of $0.051

BUDA news

  • Press releaseBusiness Wire

    Buda Juice to Participate in the LD Micro 20th Annual Main Event on October 20, 2026

  • Press releaseBusiness Wire

    Buda Juice Reports Second Quarter 2026 Financial Results

  • Press releaseBusiness Wire

    Buda Juice Announces Second Quarter Fiscal 2026 Financial Results Conference Call and Webcast

  • Press releaseBusiness Wire

    Buda Juice to Present at the Planet MicroCap Las Vegas 2026 Conference Powered by MicroCapClub

  • Press releaseBusiness Wire

    Buda Juice Dual Lists on the NYSE Texas Exchange

  • Buda Juice Reports Q1 2026 Results: Full Earnings Call Transcript

  • Press releaseBusiness Wire

    Buda Juice Reports First Quarter Fiscal 2026 Financial Results

  • Press releaseBusiness Wire

    Buda Juice Expands Distribution Across Nine States

Similar companies

Companies in the same industry as Buda Juice

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.